Electronic Cigarettes as a Harm Reduction Strategy Among People With Opioid Use Disorder on Buprenorphine
Part of paid clinical trials in Greenville, South Carolina.
- Sponsor
- Prisma Health-Upstate
- Study ID
- NCT07202039
- Status
- Recruiting
Conditions
- Sweet Non-cooling EC
- Sweet-Cooling EC
- Tobacco-flavored EC
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Brief individual counseling sessions — BEHAVIORALFive brief, individual counseling sessions will provide education, behavioral support, and motivational strategies to facilitate switching from combustible cigarette use to EC
Study Details
This project aims to investigate the impact of e-cigarette flavors and usage patterns on achieving harm-reduction milestones in a sample of cigarette smokers with opioid use disorder who are taking buprenorphine
Key Dates
- Start date
- Apr 29, 2026
- Status verified
- May 2026
- Primary completion
- Mar 30, 2029
- Completion
- Jun 29, 2029
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Sweet-Cooling EC + CounselingThose randomized to the intervention group will be provided a free 12-week supply of sweet-cooling electronic cigarette (EC) liquid and five brief, individual counseling sessions, and asked to try to switch completely to EC.
- Experimental: Sweet non-cooling EC + CounselingThose randomized to the intervention group will be provided a free 12-week supply of sweet non-cooling electronic cigarette (EC) liquid and five brief, individual counseling sessions, and asked to try to switch completely to EC.
- Active Comparator: Tobacco-flavored EC + CounselingThose randomized to the intervention group will be provided a free 12-week supply of tobacco-flavored electronic cigarette (EC) liquid and five brief, individual counseling sessions, and asked to try to switch completely to EC.
Primary Outcome Measure
Change in cigarettes smoked per day [ Time Frame: Baseline to week 12 ]
Central Contacts
- Irene Pericot-Valverde, PhD(864)656-4467
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Addiction Medicine Center | Greenville | South Carolina | 29605 |
Find similar trials in Greenville, SC
By research site